John Do is an experienced domestic and international financial executive and board member with more than 23 years of success in finance, strategy, mergers and acquisition, start-up and corporate turn-around. “Since enlisting in the healthcare transformation journey at Walgreens Boots Alliance in 2021, he has demonstrated unparalleled leadership, strategic vision and unwavering commitment,” said his colleagues.
Walgreens Boots Alliance (WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day with a 170-year heritage of caring for communities. A trusted, global innovator in retail pharmacy with approximately 13,0000 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem.
Under Do’s leadership, the healthcare division has grown to $8 billion in annualized revenue and has acquired or organically launched healthcare services covering advanced primary care, urgent care, specialty care, post-acute and home health, clinical trials and retail healthcare destinations. Do also supported the launch of Walgreens Clinical Trials business in June 2022.
“Throughout his career, John’s passion for healthcare has been a driving force in the trajectory of his work as he’s dedicated efforts to catalyzing transformative change in the healthcare industry,” said his staff. “His expertise has been honed through years of advocating for equitable access, innovative treatments and patient-centric care and this passion extends beyond profits as he upholds a commitment to shaping a healthier world for all.”
Prior to his appointment at WAB, Do launched and scaled up Anthem’s healthcare services division while driving in more than $10 billion in annual sales for his oversight of the eight companies. While at DaVita Healthcare Partners, Do was instrumental in growing the company from zero to 300 clinics.
Do is known as a titan in his industry with a successful track record of achieving high growth and improving profitability across a variety of geographies and stages of growth. His influence and expertise have ensured financial health of organizations but has also facilitated critical investments in new healthcare solutions and technologies, said his staff. “To put it simply, John is able to seamlessly navigate the intricacies of healthcare while remaining committed to improving patient outcomes, maintaining compliance and contributing to organizational growth in the evolving healthcare landscape,” they said. “His dedication to fiscal excellence sets a standard across the board that many in his industry strive to maintain.
For his dedication to the healthcare industry and fiscal excellence, Do has been named a Titan 100.
